Literature DB >> 33654063

The prevalence of antibodies to SARS-CoV-2 among blood donors in China.

Le Chang1,2, Wangheng Hou3,4, Lei Zhao5,6, Yali Zhang3,4, Yanbin Wang7, Linfeng Wu8, Tingting Xu5,6, Lilin Wang8, Juan Wang3,4, Jian Ma3,4, Lan Wang9, Junpeng Zhao8, Jing Xu9, Juan Dong5,6, Ying Yan1,2, Ru Yang10, Yu Li5,6, Fei Guo1,2, Wenjuan Cheng5,6, Yingying Su3,4, Jinfeng Zeng8, Wei Han7, Tong Cheng3,4, Jun Zhang3,4, Quan Yuan11,12, Ningshao Xia3,4, Lunan Wang13,14,15.   

Abstract

In this study, we investigate the seroprevalence of SARS-CoV-2 antibodies among blood donors in the cities of Wuhan, Shenzhen, and Shijiazhuang in China. From January to April 2020, 38,144 healthy blood donors in the three cities were tested for total antibody against SARS-CoV-2 followed by pseudotype SARS-CoV-2 neutralization tests, IgG, and IgM antibody testing. Finally, a total of 398 donors were confirmed positive. The age- and sex-standardized SARS-CoV-2 seroprevalence among 18-60 year-old adults (18-65 year-old in Shenzhen) was 2.66% (95% CI: 2.24%-3.07%) in Wuhan, 0.033% (95% CI: 0.0029%-0.267%) in Shenzhen, and 0.0028% (95% CI: 0.0001%-0.158%) in Shijiazhuang, respectively. Female sex and older-age were identified to be independent risk factors for SARS-CoV-2 seropositivity among blood donors in Wuhan. As most of the population of China remained uninfected during the early wave of the COVID-19 pandemic, effective public health measures are still certainly required to block viral spread before a vaccine is widely available.

Entities:  

Year:  2021        PMID: 33654063     DOI: 10.1038/s41467-021-21503-x

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  3 in total

1.  Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment?

Authors:  A Di Stadio; A Della Volpe; M Ralli; G Ricci
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-05       Impact factor: 3.507

Review 2.  The Role of Antibody Testing for SARS-CoV-2: Is There One?

Authors:  Elitza S Theel; Patricia Slev; Sarah Wheeler; Marc Roger Couturier; Susan J Wong; Kamran Kadkhoda
Journal:  J Clin Microbiol       Date:  2020-07-23       Impact factor: 5.948

3.  Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.

Authors:  Baweleta Isho; Kento T Abe; Michelle Zuo; Alainna J Jamal; Bhavisha Rathod; Jenny H Wang; Zhijie Li; Gary Chao; Olga L Rojas; Yeo Myong Bang; Annie Pu; Natasha Christie-Holmes; Christian Gervais; Derek Ceccarelli; Payman Samavarchi-Tehrani; Furkan Guvenc; Patrick Budylowski; Angel Li; Aimee Paterson; Feng Yun Yue; Lina M Marin; Lauren Caldwell; Jeffrey L Wrana; Karen Colwill; Frank Sicheri; Samira Mubareka; Scott D Gray-Owen; Steven J Drews; Walter L Siqueira; Miriam Barrios-Rodiles; Mario Ostrowski; James M Rini; Yves Durocher; Allison J McGeer; Jennifer L Gommerman; Anne-Claude Gingras
Journal:  Sci Immunol       Date:  2020-10-08
  3 in total
  9 in total

Review 1.  SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis.

Authors:  Mobin Azami; Yousef Moradi; Asra Moradkhani; Abbas Aghaei
Journal:  Eur J Med Res       Date:  2022-06-02       Impact factor: 4.981

2.  Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron.

Authors:  Siling Wang; Hui Sun; Yali Zhang; Lunzhi Yuan; Yizhen Wang; Tianying Zhang; Shaojuan Wang; Jinlei Zhang; Hai Yu; Hualong Xiong; Zimin Tang; Liqin Liu; Yang Huang; Xiuting Chen; Tingting Li; Dong Ying; Chang Liu; Zihao Chen; Quan Yuan; Jun Zhang; Tong Cheng; Shaowei Li; Yi Guan; Qingbing Zheng; Zizheng Zheng; Ningshao Xia
Journal:  Cell Rep       Date:  2022-05-08       Impact factor: 9.995

3.  Seroprevalence and characteristics of Coronavirus Disease (COVID-19) in workers with non-specific disease symptoms.

Authors:  Wajiha Javed; Syed Hussain Baqar Abidi; Jaffer Bin Baqar
Journal:  BMC Infect Dis       Date:  2022-05-20       Impact factor: 3.667

4.  Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi-challenges in acquiring herd immunity for COVID 19.

Authors:  Samreen Zaidi; Faiza Rizwan; Quratulain Riaz; Asma Siddiqui; Shabnam Khawaja; Mehjabeen Imam; Arshi Naz; Samra Waheed; Tahir Shamsi
Journal:  J Public Health (Oxf)       Date:  2021-04-12       Impact factor: 2.341

5.  SARS-CoV-2 IgG Surveillance in Asymptomatic Blood Donors and Health Workers.

Authors:  Tulika Chandra; Devisha Agarwal; D Himanshu; Mallika Agarwal; Bipin Puri
Journal:  Adv Med       Date:  2021-12-29

6.  SARS-CoV-2 IgG Seroprevalence among Blood Donors as a Monitor of the COVID-19 Epidemic, Brazil.

Authors:  Daniel Gonçalves Chaves; Ricardo Hiroshi Caldeira Takahashi; Felipe Campelo; Maria Clara Fernandes da Silva Malta; Isabelle Rocha de Oliveira; Edel Figueiredo Barbosa-Stancioli; Maísa Aparecida Ribeiro; Marina Lobato Martins
Journal:  Emerg Infect Dis       Date:  2022-02-18       Impact factor: 6.883

7.  Seroprevalence of anti-severe acute respiratory syndrome coronavirus 2 antibody among healthy blood donors in a hospital-based blood center in Eastern India during the COVID-19 pandemic.

Authors:  Sudipta Sekhar Das; Subhas Chandra Bera; Rathindra Nath Biswas
Journal:  Asian J Transfus Sci       Date:  2022-05-26

8.  Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation.

Authors:  Natalia Martinez-Acuña; Diana Minerva Avalos-Nolazco; Diana Raquel Rodriguez-Rodriguez; Cynthia Gabriela Martinez-Liu; Kame Alberto Galan-Huerta; Gerardo Raymundo Padilla-Rivas; Javier Ramos-Jimenez; Sergio Ayala-de-la-Cruz; Eduardo Cienfuegos-Pecina; Erik Alejandro Diaz-Chuc; Rogelio Cazares-Tamez; Amador Flores-Arechiga; Fernando Perez-Chavez; Daniel Arellanos-Soto; Sonia Amelia Lozano-Sepulveda; Elvira Garza-Gonzalez; Consuelo Treviño-Garza; Roberto Montes-de-Oca-Luna; Aurora Beatriz Lee-Gonzalez; Manuel Enrique de-la-O-Cavazos; Ana Maria Rivas-Estilla
Journal:  Viruses       Date:  2021-06-24       Impact factor: 5.048

9.  Effect of the first year of COVID-19 pandemic on the collection and use of blood components in Colombia monitored through the national haemovigilance system.

Authors:  María-Isabel Bermúdez-Forero; Jonathan-Andrés Soto-Viáfara; Paula-Andrea Gardeazábal-Acuña; Diego-Alexander Anzola-Samudio; Michel-Andrés García-Otálora
Journal:  Transfus Med       Date:  2021-10-24       Impact factor: 2.057

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.